Silence Therapeutics reported 1.14M in Sales Revenues for its fiscal quarter ending in September of 2024.


Sales Change Date
AstraZeneca USD 14.46B 867M Jun/2025
Autolus Therapeutics Ltd 20.9M 18.8M Jun/2025
Hikma Pharmaceutical USD 1.59B 18M Dec/2024
Novartis USD 14.05B 821M Jun/2025
Roche Holding CHF 31.64B 883M Dec/2024
Silence Therapeutics 1.14M 544K Sep/2024